Vascular Tack Endovascular System recalled for deployment and migration risks
Spectranetics' Intact Vascular Tack Endovascular System may fail to deploy properly or migrate in blood vessels, potentially causing ischemia and requiring additional intervention.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: FDA Class I classification qualifies this recall as Critical per the rubric. The documented hazards—including device migration, deployment failure, and ischemia (tissue death from blood flow loss)—represent serious potential for patient harm.
Plain-English summary
Spectranetics Corporation is recalling the Intact Vascular Tack Endovascular System, a medical device designed to treat acute tears (dissections) in artery linings by securing damaged tissue to the inner vessel wall using small tack implants. The FDA classified this recall as Class I due to potential problems with device deployment and stability after placement in blood vessels.
When the tack system does not deploy or remain stable as intended, it may fail to resolve the dissection, allowing the implant to migrate within the vessel. Patients may require additional interventions including bailout stenting, re-treatment, or unintended removal of tack devices. The most serious potential consequence is ischemia—a dangerous reduction in blood flow that can damage or kill tissue.
Approximately 2,939 units of the Intact Vascular Tack Endovascular System have been distributed across the United States and internationally. Healthcare providers should immediately discontinue use and consult with the FDA and Spectranetics regarding patient management options for patients who have received these devices.
The recalled product
- Product
- Intact Vascular Tack Endovascular System, to treat vascular dissections with Tack implant(s) following angioplasty: (4F,1.5-4.5mm), 150cm, REF: 154150041; Tack, 4F Gen 1.5, 150cm CE, REF: 154150042; Tack, 4F Gen 1.5, 90cm CE, REF: 154090042 (6F, 3.5 - 6.0mm), 135cm, REF: 15613
- Manufacturer
- Spectranetics Corporation
- Affected units
- 2,939
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- UDI-DI: REF/UDI-DI/Batch: 154150041/00863328000189/332905 - 349049
- 154150042/328641
- REF: 154090042/322101
- 156135061/00863328000103/332824 - 336121
- 206135061/00850003494043/331281 - 336152
- 206135062/328643 - 345567
- 156135062/271330 - 283066
- 206080062/321083 - 349035
- 156080062/302251 - 349034
Distribution
Related recalls
Same manufacturer · Spectranetics Corporation
See all →- HighLaser Atherectomy Catheter Recalled for Marker Band Detachment Risk
FDA (Devices) · 2024-12-25
- ModerateSpectranetics Turbo-Elite Atherectomy Catheters recalled due to labeling mismatch
FDA (Devices) · 2023-12-20
- HighPhilips Laser System may enter non-recoverable error state
FDA (Devices) · 2022-11-23
- ModeratePhilips LAS-100 Laser System may not operate due to detected hardware failure
FDA (Devices) · 2022-07-20
- HighSpectranetics Bridge Occlusion Balloon Recalled for Thrombus Formation Risk
FDA (Devices) · 2020-06-03
Same hazard · deployment failure
See all →- SevereGORE TAG Thoracic Branch Endoprosthesis Side Branch Component Recall
FDA (Devices) · 2026-07-08
- HighCGuard Prime 9mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 10mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 9mm carotid stent systems may resist or fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 8mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17